Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases

Published:2012-03 Issue:1 Volume:50 Page:3-13
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Ishikawa Nobuhisa,Hattori Noboru,Yokoyama Akihito,Kohno Nobuoki

Funder

Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference102 articles.

1. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS);American Thoracic Society;Am J Respir Crit Care Med,2000

2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias

3. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management;Raghu;Am J Respir Crit Care Med,2011

4. Proteomic approaches for studying human parenchymal lung diseases;Kinnula;Expert Rev Proteomics,2009

5. Clinical advances in the diagnosis and therapy of the interstitial lung diseases;King;Am J Respir Crit Care Med,2005

Cited by 313 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease;Tissue and Cell;2024-10

2. Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: A meta-analysis;Biomolecules and Biomedicine;2024-09-06

3. CA 15 − 3 in screening for systemic autoimmune rheumatic disease associated interstitial lung disease: a single center cross-sectional study;Rheumatology International;2024-08-24

4. Diagnostic Value of Serum KL-6 in Interstitial Lung Diseases;International Journal of General Medicine;2024-08

5. Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease;Rheumatic Disease Clinics of North America;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3